1800-272-662
Shopping Cart 0
countryflagAU
Login

RadNet Inc

Healthcare US RDNT

60.83USD
-1.5(2.41%)

Last update at 2026-03-10T20:00:00Z

Day Range

59.0962.29
LowHigh

52 Week Range

45.0093.65
LowHigh

Fundamentals

  • Previous Close 62.33
  • Market Cap4587.34M
  • Volume826756
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA224.19M
  • Revenue TTM1869.36M
  • Revenue Per Share TTM25.16
  • Gross Profit TTM 347.80M
  • Diluted EPS TTM-0.43

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 42.97M 58.88M -0.85400M 29.67M 38.53M
Minority interest 22.96M 19.59M 92.56M 8.68M 5.89M
Net income 33.61M 44.32M -1.74900M 23.44M 32.24M
Selling general administrative 1265.29M 1124.02M 970.25M 1001.31M 869.48M
Selling and marketing expenses - - - - -
Gross profit 165.72M 191.80M 105.94M 154.49M 107.60M
Reconciled depreciation 184.72M 170.66M 154.71M 147.45M 72.90M
Ebit 46.36M 82.55M 53.23M 69.88M 85.80M
Ebitda 243.12M 264.73M 207.94M 229.16M 158.70M
Depreciation and amortization 196.76M 182.18M 154.71M 159.29M 72.90M
Non operating income net other 47.45M 25.16M 9.34M 7.83M 51.10M
Operating income 46.36M 82.55M 53.23M 69.88M 30.89M
Other operating expenses 1380.22M 1210.86M 1026.43M 1080.30M 940.45M
Interest expense 50.84M 48.83M 45.88M 48.04M 43.46M
Tax provision 9.36M 14.56M 0.90M 6.23M 0.39M
Interest income - - - 39.69M 39.54M
Net interest income -50.84100M -48.83000M -45.88200M -48.04400M -43.45600M
Extraordinary items - - - - -
Non recurring 2.53M 1.25M 5.37M 2.38M 1.88M
Other items - - - - -
Income tax expense 9.36M 14.56M 0.90M 6.23M 0.39M
Total revenue 1430.06M 1315.08M 1071.84M 1154.18M 975.15M
Total operating expenses 115.88M 87.58M 60.53M 80.61M 72.90M
Cost of revenue 1264.35M 1123.27M 965.90M 999.69M 867.55M
Total other income expense net -3.39400M -23.67500M -54.08600M -40.20900M 47.28M
Discontinued operations - - - - -
Net income from continuing ops 33.61M 44.32M -1.74900M 23.44M 38.13M
Net income applicable to common shares 10.65M 24.73M -14.84000M 14.76M 32.24M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 3286.69M 2886.69M 2433.91M 2058.47M 1786.66M
Intangible assets 81.35M 90.61M 106.23M 56.60M 52.39M
Earning assets - - - - -
Other current assets 51.54M 47.66M 54.02M 49.21M 32.98M
Total liab 2153.28M 2073.33M 1942.45M 1712.32M 1528.35M
Total stockholder equity 902.31M 630.70M 333.00M 228.90M 165.74M
Deferred long term liab - - 2.28M 2.13M 1.77M
Other current liab 298.66M 235.96M 23.10M 23.53M 14.01M
Common stock 0.00700M 0.00700M 0.00600M 0.00500M 0.00500M
Capital stock 0.00700M 0.00700M 0.00600M 0.00500M 0.00500M
Retained earnings -76.78500M -79.57800M -82.62200M -93.27200M -117.99900M
Other liab - - 32.27M 16.36M 53.49M
Good will 710.66M 679.46M 677.66M 513.82M 472.88M
Other assets - - 55.45M 53.02M 73.44M
Cash 740.02M 342.57M 127.83M 134.61M 102.02M
Cash and equivalents - - - - -
Total current liabilities 479.71M 437.45M 466.72M 374.78M 398.11M
Current deferred revenue 3.29M 4.65M 4.02M 10.70M 39.26M
Net debt 988.84M 1148.55M 1385.63M 1263.18M 1082.90M
Short term debt 81.31M 73.95M 70.01M 76.62M 108.16M
Short long term debt 24.69M 17.97M 12.40M 11.16M 39.79M
Short long term debt total 1728.86M 1491.12M 1513.47M 1397.79M 1184.91M
Other stockholder equity 988.15M 722.75M 436.29M 342.59M 307.79M
Property plant equipment - - 565.96M 1068.54M 883.00M
Total current assets 1019.25M 579.28M 367.18M 324.26M 270.42M
Long term investments 104.06M 92.71M 57.89M 42.23M 34.53M
Net tangible assets - - -450.89800M -341.51900M -359.52900M
Short term investments - - - - 34.53M
Net receivables 227.69M 189.05M 185.33M 140.45M 135.42M
Long term debt 991.57M 812.07M 839.34M 743.50M 612.91M
Inventory - 0.00000M - - -
Accounts payable 96.45M 122.89M 369.60M 263.94M 236.68M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - 158.46M 117.25M 92.56M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -9.06100M -12.48400M -20.67700M -20.42100M -24.05100M
Additional paid in capital - - - - -
Common stock total equity - - 0.00600M 0.00500M 0.00500M
Preferred stock total equity - - - - -
Retained earnings total equity - - -82.62200M -93.27200M -117.99900M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 36.84M 47.98M 55.45M 38.17M 38.75M
Deferred long term asset charges - - - - -
Non current assets total 2267.44M 2307.42M 2066.72M 1734.21M 1516.23M
Capital lease obligations 712.60M 661.08M 661.72M 643.13M 532.21M
Long term debt total - - 839.34M 743.50M 612.91M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.44100M -1.44100M -126.24400M 0.68M -4.20000M
Change to liabilities 42.46M 1.43M 82.40M 16.23M 27.76M
Total cashflows from investing activities -246.94900M -221.51100M -126.24400M -99.46500M -146.74900M
Net borrowings 94.25M 94.48M -42.83500M 21.91M -11.90200M
Total cash from financing activities 93.65M 104.67M -45.56100M 24.95M -10.86900M
Change to operating activities -84.43600M -87.66800M -52.74300M -72.71400M -4.62300M
Net income 33.61M 44.32M -1.74900M 23.44M 38.13M
Change in cash -6.77200M 32.59M 61.85M 29.78M -40.93300M
Begin period cash flow 134.61M 102.02M 40.16M 10.39M 51.32M
End period cash flow 127.83M 134.61M 102.02M 40.16M 10.39M
Total cash from operating activities 146.42M 149.49M 233.76M 104.32M 116.75M
Issuance of capital stock - - - - -
Depreciation 184.72M 170.66M 154.71M 147.45M 72.90M
Other cashflows from investing activities -126.05700M -82.19600M -30.43700M 1.16M 2.82M
Dividends paid - 6.26M 1.58M - 1.43M
Change to inventory - -87.66800M -45.06900M -17.31600M -10.93500M
Change to account receivables -30.07800M -5.89000M 25.21M -17.48200M 2.15M
Sale purchase of stock -0.59900M -1.93800M -1.98500M -2.98200M -1.60700M
Other cashflows from financing activities 147.10M 855.80M 252.20M 361.39M 205.33M
Change to netincome -6.24300M 42.98M 34.61M 4.35M 16.08M
Capital expenditures 249.41M 220.69M 125.44M 101.30M 145.37M
Change receivables -30.07800M -5.89000M 25.21M -17.48200M 2.15M
Cash flows other operating -15.58900M 5.97M 15.41M -7.01100M -44.16200M
Exchange rate changes - - - -0.03200M -0.06900M
Cash and cash equivalents changes -6.88500M 32.65M 61.95M 29.78M -40.93300M
Change in working capital -58.69600M -92.12800M 54.86M -77.85000M 18.35M
Stock based compensation 23.77M 25.20M 12.40M 8.73M 7.66M
Other non cash items -50.34500M 22.93M 4.66M 0.69M -13.35400M
Free cash flow -102.99500M -71.20400M 108.32M 3.02M -28.61800M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RDNT
RadNet Inc		 -1.5 2.41% 60.83 - - 2.45 5.11 3.00 19.33
TMO
Thermo Fisher Scientific Inc		 -9.89 1.94% 500.08 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 -3.58 1.80% 195.22 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc		 -1.21 1.04% 115.43 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc		 -11.6 1.90% 598.85 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

View All

Profile

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RadNet Inc

1510 Cotner Avenue, Los Angeles, CA, United States, 90025

Key Executives

Name Title Year Born
Dr. Howard G. Berger M.D. Chairman, Pres & CEO 1946
Mr. Mark D. Stolper Exec. VP & CFO 1971
Mr. Mital Patel Exec. VP of Financial Planning & Analysis and Chief Admin. Officer 1986
Mr. Norman R. Hames Pres & COO of Western Operations 1956
Mr. Stephen M. Forthuber Pres & COO of Eastern Operations 1961
Ms. Christine Nayoma Gordon Sr. VP of Operations - Northern California & Director 1963
Ms. Ruth Louisa Villiger-Wilson HR Advisor & Director 1964
Mr. Ranjan Jayanathan Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division 1956
Ms. Laura Foster BSRT, MPH, J.D. Sr. VP of Compliance & Regulatory Affairs NA
Mr. David Jeffrey Katz Exec. VP, Gen. Counsel & Corp. Sec. 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.